News | Cystic Fibrosis Foundation

About the CF Foundation | Research | Drug Pipeline

CF Foundation Relays Patients' Concerns about Pancreatic Enzymes to FDA

May. 17, 2010 | 3 min read

Research

FDA Approves Third Pancreatic Enzyme Product: Pancreaze Delayed-Release Capsules

The U.S. Food and Drug Administration (FDA) has approved PancreazeTM delayed-release capsules, a pancreatic enzyme replacement therapy. This is the third such product to receive approval. Pancreaze is manufactured by Johnson & Johnson.

Apr. 15, 2010 | 1 min read

Research

CF Foundation’s Drug Discovery Investment Leads Galapagos to Pursue CF Drug Development

Mar. 19, 2010 | 1 min read

Research

CF Foundation Plays Important Role in Bringing New Inhaled Antibiotic Cayston to Patients

The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis (CF).

Feb. 22, 2010 | 3 min read

About the CF Foundation | Research | Drug Pipeline

Cystic Fibrosis is Proof of Principle for Drug Development for Rare Diseases, says NIH Director on Minnesota Public Radio

Jan. 20, 2010 | 1 min read